ML44399, "A multicenter trial to identify optimal atezolizumab biomarkers in the setting of recurrent gliobastoma. The MOAB Trial.
Clinical Trial Grant
Awarded By
Genentech, Inc.
Start Date
October 5, 2023
End Date
October 31, 2027
Awarded By
Genentech, Inc.
Start Date
October 5, 2023
End Date
October 31, 2027